PE-22-28
A practical guide to research stage, controls, endpoints, uncertainty, and applicability.
At a glance
- Evidence stage
- Preclinical
- Regulatory status
- PE-22-28 is not FDA-approved for any use; research material sold under this name is not a regulated drug product.
- Research context
- PE-22-28 is studied mainly in laboratory and animal (preclinical) cognitive wellness research; mechanism and animal findings do not establish human safety or benefit.
What this is
- PE-22-28 is discussed here as a subject of laboratory and animal (preclinical) research.
- Published findings focus on mechanism and early biology, not proven outcomes in people.
- PE-22-28 is not an FDA-approved drug for any consumer, clinical, or performance use.
What this isn't
- This page is not medical advice or a treatment recommendation involving PE-22-28.
- This is not a dosing guide — no dose, schedule, or administration instructions are implied.
- This is not proof that PE-22-28 is safe or effective for use in humans.
Key terms
Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Start by identifying the research stage and exact molecule. Then examine the comparison group, participant selection, endpoint, follow-up, missing data, adverse-event reporting, and funding. A statistically detectable result may still be small, uncertain, or irrelevant to patient goals. For background on the field, see this NIH-hosted therapeutic peptide review.
Evidence limits
How to read the evidence
Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Check preregistration, multiplicity, absolute rather than relative effects, confidence intervals, attrition, subgroup credibility, and whether the conclusion matches the measured endpoint.
Coverage
In the news
Recent reporting about this molecule. Headlines are not clinical guidance.
- In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides - STATSTAT · 2026-07-23 · External ↗
- What to Know About Peptides the FDA Is Considering for Use - The New York TimesThe New York Times · 2026-07-23 · External ↗
- FDA advisers recommend relaxing US rules on compounding peptides - ReutersReuters · 2026-07-24 · External ↗
External sources and citations
- Spadin Selectively Antagonizes Arachidonic Acid Activation of TREK-1 Channels. Frontiers in pharmacology, 2020
- Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity. Frontiers in pharmacology, 2017
- Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin. Pharmacology & therapeutics, 2019
- Spadin Modulates Astrocytic Passive Conductance via Inhibition of TWIK-1/TREK-1 Heterodimeric Channels. International journal of molecular sciences, 2020
- Spadin as a new antidepressant: absence of TREK-1-related side effects. Neuropharmacology, 2012
- Retroinverso analogs of spadin display increased antidepressant effects. Psychopharmacology, 2015
- Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS biology, 2010
- The Involvement of Sortilin/NTSR3 in Depression as the Progenitor of Spadin and Its Role in the Membrane Expression of TREK-1. Frontiers in pharmacology, 2018
Common questions
What is PE-22-28?
PE-22-28 is discussed in research and educational contexts as a named molecule or product label. Identity, purity, and studied form can differ across sources — a name match alone is not proof of the same material used in a study.
What does the evidence for PE-22-28 actually show?
Evidence for PE-22-28 ranges by question: preclinical models, early human work, or approved uses for specific indications. Mechanism findings and animal data do not automatically predict clinical benefit or safety in people.
Is PE-22-28 FDA-approved for general use?
Do not assume PE-22-28 is FDA-approved for the use you have in mind. Approvals are indication-specific. Many research peptides and compounded products are not approved drugs for consumer or athletic use.
What product-quality questions should I ask about PE-22-28?
Ask what was tested (identity, purity, potency), who tested it, and whether the label matches the studied form. Third-party certificates, storage conditions, and supplier transparency matter more than marketing claims.
How is PE-22-28 different from similarly named products?
Blends, salts, fragments, and brand nicknames are often confused with PE-22-28. Verify the exact molecule, dose unit, and route in any citation before treating it as evidence for a different product.
Related peptides
Other published briefs in the same research family. Educational references only - not treatment recommendations.
BDNF
Peer review is a quality filter, not a guarantee of truth or clinical applicability.
Open resourcePeptide briefDavunetide (NAP)
A valuable case study in how a plausible neuroprotective mechanism can fail in a large human trial.
Open resourcePeptide briefDihexa
Why hepatocyte growth factor / synaptic research does not justify memory or focus promises.
Open resourcePeptide briefDihexa / Tesofensine / BPC-157
Why hepatocyte growth factor / synaptic research does not justify memory or focus promises.
Open resourcePeptide briefDSIP
Why delta sleep-inducing peptide research is not the same as a proven sleep treatment.
Open resourcePeptide briefMethylene Blue / Methylliberine
Why the same acronym can refer to different molecules, salts, fragments, or blends.
Open resourceLearn the research basics
Foundational literacy pieces that help interpret evidence stage, product identity, and study design.
How to read a peptide study without overclaiming
A practical guide to research stage, controls, endpoints, uncertainty, and applicability.
Open resourceLiteracyWhy a biological mechanism is not a treatment promise
A practical explanation of why plausible pathways still need meaningful human-outcome evidence.
Open resourceLiteracyPeptide naming, aliases, and product identity
Why the same acronym can refer to different molecules, salts, fragments, or blends.
Open resourceLiteracyFrom preclinical finding to human evidence
Why a compelling cell or animal result is the beginning of a question, not the end of it.
Open resourceLiteracyFDA approved, compounded, and unapproved are not synonyms
A plain-language map of product categories that are often blurred in peptide discussions.
Open resourceLiteracyUnderstanding surrogate endpoints in peptide research
When a laboratory value changes but patient outcomes remain uncertain.
Open resourceWatch & read
Same-family videos and articles from the Articles & Media channel. Educational references only.
Dr. Andrew Huberman — Peptides, Performance, and Protocols
Andrew Huberman, Ph.D., is a neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at Stanford University School of Medicine, where he runs the Huberman Lab. He is the author of Protocols: An Operating Manual for the Human Body: https://www.amazon.com/Protocols-Operating-Manual-Human-Body/dp/1668032147?tag=offsitoftimfe-20 This episode is brought to you by: ProLon science-backed Fasting Mimicking Diet that helps activate cellular renewal through fasting, while still eating nourishing meals: https://prolonlife.com/Tim Eight Sleep Pod Cover 5 sleeping solution for dynamic cooling and heating: https://www.eightsleep.com/tim/ Momentous high-quality creatine for cognitive and muscular support: https://livemomentous.com/Tim Helix Sleep premium mattresses: https://helixsleep.com/tim *** Show notes: https://tim.blog/2026/07/22/dr-andrew-huberman-protocols/ [00:00] Preview. [00:42] Dean Potter, The Dark Wizard, and the physics of raw energy. [02:45] Why competition destroys performance. [04:06] Laird Hamilton, tow-in surfing, and the lure of big waves. [04:56] Training with Dorian Yates. [14:25] The full weekly split that keeps building strength at 50. [16:50] Neck training. [21:55] AssaultBike vs. Airdyne. [27:24] Revisiting MDMA and psychedelics. [41:00] Inducing plasticity is only half the job. [46:17] The one-day protocol that cut my anxiety by 90%. [53:25] Cortisol as the master key. [56:24] Peptides demystified: GLP-1s, growth hormone, and BPC-157. [01:07:41] The Enhanced Games, the Deca burrito, and the honesty problem. [01:10:47] Pinealon, epitalon, and the hunt for more REM sleep. [01:18:04] Why women, not gym bros, are the real peptide market. [01:28:55] Why "no reported side effects" is a trap. [01:36:14] Stem cells, cartilage regrowth, and mining the body for medicine. [01:39:50] AI, wearables, and the race to write to the nervous system. [01:46:00] The MIT mask that puts you to sleep in six minutes. [01:49:32] Inside An
Open resourceVideoAre There Better Fixes for ADHD, Brain Fog? Peptides, Supplements & Biohacks
Can’t finish a thought? Overwhelmed or ADHD? Doctor Froese explains the biology of focus—and some clever hacks, supplements, and peptides to get your clarity, motivation, and attention back. Work 1-on-1 with Dr. Froese : https://drafroese.com/
Open resourceVideoThe Best Peptide for Brain Function, Memory and Cognition | TB500 Thymosine Beta 4
Use Code THOMAS for 50% off Hiya: https://www.hiyahealth.com/thomas New Peptide For the Brain Shows Promising Results This video does contain a paid partnership with a brand that helps to support this channel. It is because of brands like this that we are able to provide the content that we do for free. Click HERE to Subscribe: https://www.youtube.com/c/ThomasDeLauerOfficial?sub_confirmation=1 Please check out the new Shorts channel, DeLauer Clips and Workouts, here: https://www.youtube.com/channel/UCQPQImPsw74KhO0Zy2-leyA/videos Please Subscribe to my Email Newsletter Here: https://www.thomasdelauer.com/life-optimization-tactics/ Follow More of My Daily Life on Instagram: http://www.Instagram.com/ThomasDeLauer References https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-021-02166-3 https://journals.sagepub.com/doi/full/10.1177/2058739220934559 Timestamps ⏱ 0:00 - Intro 1:08 - Use Code THOMAS for 50% off Hiya! 2:04 - Thymosin β4 6:33 - Dosing
Open resourceVideoThese Peptides Can Maximize Your Cognitive Function
Discover how specific peptides like Dihexa, Semax, Selank, and more can enhance memory, focus, and overall brain performance. In this video, we break down what each peptide does and why they’re being called nootropic game-changers. Click Here: https://agelessfuture.com/ Download your FREE copy of my Peptide Blueprint here: https://www.agelessfuture.com/blueprint Watch And Enjoy! Regan Archibald Key Moments In This Episode ======================== 00:00 Intro & Summary 00:45 What Are Peptides 01:50 What Is Dihexa 03:21 What Is Semax 03:59 What Is Selank 05:03 What Is Cerebrolysin 06:43 What Is RG# (Synapsin) 08:05 The Most Powerful Peptides What To Watch Next ======================== A Closer Look At Internasal Stem Cells For Cognitive Function https://youtu.be/ZrQe-eTBI04 Connect with Us: ======================== Website: https://agelessfuture.com/ Contact Us: regan@agelessfuture.com Call Us: (801) 582-2011 🚀 About Regan Archibald ======================== The Ageless Future Operating System is designed to help you look, feel, and perform your best at any age. There are four essential quadrants that to create your personalized path to vibrant health: Clarify, Diagnose, Predict, Rejuvenate. The Peptide Pathway Bypass™ is a core component of the Ageless Future Operating System™ (AFOS), focused on leveraging the science of peptides to optimize health, activate energy generation, and rejuvenate the body at the cellular level. To create your Ageless Future roadmap, connect with us. ======================== Video by Nate Woodbury BeTheHeroStudios.com http://YouTube.com/c/NateWoodbury #Biohacking #cognitiveenhancement DISCLAIMER: This video is for educational purposes only and does not provide medical advice, diagnosis, or treatment. Many of the molecules discussed in this video are research compounds and are not approved by the U.S. Food and Drug Administration (FDA) for any specific medical use, indication, or condition. They are mentioned only in the c
Open resourceArticleA clinical-trial record is not proof that a peptide works
What a trial registry can tell you, what it cannot, and how to avoid overreading a study status.
Open resourceArticleSemax: cognitive research without overclaiming
How to read semax literature and regional regulatory context without turning a mechanism into a treatment promise.
Open resourceArticleDSIP: sleep-peptide research in context
Why delta sleep-inducing peptide research is not the same as a proven sleep treatment.
Open resourceArticleDihexa: cognitive neurotrophin research under scrutiny
Why hepatocyte growth factor / synaptic research does not justify memory or focus promises.
Open resourceRelated articles
Same-family articles from the published library. Educational references only - not treatment recommendations.
A clinical-trial record is not proof that a peptide works
What a trial registry can tell you, what it cannot, and how to avoid overreading a study status.
Open resourceArticleSemax: cognitive research without overclaiming
How to read semax literature and regional regulatory context without turning a mechanism into a treatment promise.
Open resourceArticleDSIP: sleep-peptide research in context
Why delta sleep-inducing peptide research is not the same as a proven sleep treatment.
Open resourceArticleDihexa: cognitive neurotrophin research under scrutiny
Why hepatocyte growth factor / synaptic research does not justify memory or focus promises.
Open resource